Carcinogens in Foods: Occurrence, Modes of Action and Modulation of Human Risks by Genetic Factors and Dietary Constituents

Epigenetics and Human Health: Linking Hereditary, Environmental and Nutritional Aspects

Volumn , Issue , 2010, Pages 105-125

  Misik M ^a   Nersesyan, A ^a   Parzefall, W ^a   Knasmuller S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cancer; Food; Genetic polymorphism; Genotoxic carcinogens; Metabolism; Protection; Risks

Indexed keywords

EID: 84884637829     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527628384.ch9     Document Type: Chapter

References (121)

1. Doll, R. (1992) The lessons of life: keynote address to the nutrition and cancer conference. Cancer Res., 52, 2024s-2029s.
2. Doll, R., and Peto, R. (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst., 66, 1191-1308.
3. Boeing, H., Dietrich, T., Hoffmann, K., Pischon, T., Ferrari, P., Lahmann, P.H. et al. (2006) Intake of fruits and vegetables and risk of cancer of the upper aero-digestive tract: the prospective EPIC-study. Cancer Causes Control, 17, 957-969.
4. World Cancer Research Fund, American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective, World Cancer Research Fund, American Institute for Cancer Research, Washington, DC.
5. Rothman, N., Correa-Villasenor, A., Ford, D.P., Poirier, M.C., Haas, R.,Hansen, J.A. et al. (1993) Contribution of occupation and diet to white blood cell polycyclic aromatic hydrocarbon-DNA adducts in wildland firefighters. Cancer Epidemiol. Biomarkers Prev., 2, 341-347.
6. Ferguson, L.R. (2002) Natural and human-made mutagens and carcinogens in the human diet. Toxicology, 181-182, 79-82.
7. Goldman, R., and Shields, P.G. (2003) Food mutagens. J. Nutr., 133 (Suppl. 3), S965-S973.
8. Ames, B.N. (1983) Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science, 221, 1256-1264.
9. Ames, B.N. (1986) Food constituents as a source of mutagens, carcinogens, and anticarcinogens. Prog. Clin. Biol. Res., 206, 3-32.
10. Ames, B.N., and Gold, L.S. (1990) Dietary carcinogens, environmental pollution, and cancer: some misconceptions. Med. Oncol. Tumor Pharmacother., 7, 69-85.
11. Khan, N., Afaq, F., and Mukhtar, H. (2008) Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid. Redox. Signal, 10, 475-510.
12. Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Koskenvuo, M. et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med., 343, 78-85.
13. Lowenfels, A.B., and Anderson, M.E. (1977) Diet and cancer. Cancer, 39, 1809-1814.
14. Phillips, D.H. (1999) Polycyclic aromatic hydrocarbons in the diet. Mutat. Res., 443, 139-147.
15. Sugimura, T. (1978) Let ' s be scientific about the problem of mutagens in cooked food. Mutat. Res., 55, 149-152.
16. Sugimura, T. (1982) Mutagens in cooked food. Basic Life Sci., 21, 243-269.
17. Sugimura, T. (1997) Overview of carcinogenic heterocyclic amines. Mutat. Res., 376, 211-219.
18. Sugimura, T., and Nagao, M. (1981) Carcinogenic, mutagenic, and comutagenic aromatic amines in human foods. Natl. Cancer Inst. Monogr., 27-33.
19. Gilbert, J. (1994) The fate of environmental contaminants in the food chain. Sci. Total Environ, 143, 103-111.
20. Dennis, M.J., Massey, R.C., McWeeny, D.J., Knowles, M.E., and Watson, D. (1983) Analysis of polycyclic aromatic hydrocarbons in UK total diets. Food Chem. Toxicol., 21, 569-574.
21. Gyorffy, E., Anna, L., Kovacs, K., Rudnai, P., and Schoket, B. (2008) Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts. Mutagenesis, 23, 1-18.
22. International Agency for Research on Cancer (1987) Overall Evaluations of Carcinogenicity to Humans, Suppl. 7, IARC, Lyon, France.
23. Sheweita, S.A. (2000) Drug-metabolizing enzymes: mechanisms and functions. Curr. Drug Metab., 1, 107-132.
24. Eaton, D.L., Gallagher, E.P., Bammler, T.K., and Kunze, K.L. (1995) Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity. Pharmacogenetics, 5, 259-274.
25. Lijinsky, W. (1999) N-Nitroso compounds in the diet. Mutat. Res., 443, 129-138.
26. Peto, R., Gray, R., Brantom, P., and Grasso, P. (1991) Dose and time relationships for tumor induction in the liver and esophagus of 4080 inbred rats by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine. Cancer Res., 51, 6452-6469.
27. Jakszyn, P., and Gonzalez, C.A. (2006) Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. World J. Gastroenterol., 12, 4296-4303.
28. Eichholzer, M., and Gutzwiller, F. (1998) Dietary nitrates, nitrites, and N-nitroso compounds and cancer risk: a review of the epidemiologic evidence. Nutr. Rev., 56, 95-105.
29. Dietrich, M., Block, G., Pogoda, J.M., Buffler, P., Hecht, S., and Preston-Martin, S. (2005) A review: dietary and endogenously formed N-nitroso compounds and risk of childhood brain tumors. Cancer Causes Control, 16, 619-635.
30. Yu, M.C., Ho, J.H., Lai, S.H., and Henderson, B.E. (1986) Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res., 46, 956-961.
31. Zhang, X.L., Bing, Z., Xing, Z., Chen, Z.F., Zhang, J.Z., Liang, S.Y. et al. (2003) Research and control of well water pollution in high esophageal cancer areas. World J. Gastroenterol., 9, 1187-1190.
32. Alaejos, M.S., Gonzalez, V., and Afonso, A.M. (2008) Exposure to heterocyclic aromatic amines from the consumption of cooked red meat and its effect on human cancer risk: a review. Food Addit. Contam., 25, 2-24.
33. Pariza, M.W., Ashoor, S.H., Chu, F.S., and Lund, D.B. (1979) Effects of temperature and time on mutagen formation in pan-fried hamburger. Cancer Lett., 7, 63-69.
34. Turesky, R.J. (2002) Heterocyclic aromatic amine metabolism, DNA adduct formation, mutagenesis, and carcinogenesis. Drug Metab. Rev., 34, 625-650.
35. Nagao, M., and Sugimura, T. (eds) (2000) Food Borne Carcinogens, Heterocyclic Amines, John Wiley & Sons, Ltd, Chichester, New York, Weinheim, Brisbaine, Singapure, Toronto.
36. Turesky, R.J. (2005) Interspecies metabolism of heterocyclic aromatic amines and the uncertainties in extrapolation of animal toxicity data for human risk assessment. Mol. Nutr. Food Res., 49, 101-117.
37. Chen, C.J., Yu, M.W., and Liaw, Y.F. (1997) Epidemiological characteristics and risk factors of hepatocellular carcinoma. J. Gastroenterol. Hepatol., 12, S294-308.
38. McLean, M., and Dutton, M.F. (1995) Cellular interactions and metabolism of aflatoxin: an update. Pharmacol. Ther., 65, 163-192.
39. Le Roux, E., Gormally, E., and Hainaut, P. (2005) Somatic mutations in human cancer: applications in molecular epidemiology. Rev. Epidemiol. Sante. Publique., 53, 257-266.
40. Grollman, A.P., Shibutani, S., Moriya, M., Miller, F., Wu, L., Moll, U. et al. (2007) Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. U. S. A., 104, 12129-12134.
41. Dutton, M.F. (1996) Fumonisins, mycotoxins of increasing importance: their nature and their effects. Pharmacol. Ther., 70, 137-161.
42. Knasmuller, S., Bresgen, N., Kassie, F., Mersch-Sundermann, V., Gelderblom, W., Zohrer, E. et al. (1997) Genotoxic effects of three Fusarium mycotoxins, fumonisin B1, moniliformin and vomitoxin in bacteria and in primary cultures of rat hepatocytes. Mutat. Res., 391, 39-48.
43. Weisburger, J.H., and Weisburger, E.K. (1968) Food additives and chemical carcinogens: on the concept of zero tolerance. Food Cosmet. Toxicol., 6, 235-242.
44. Tokiwa, H., Nakagawa, R., Horikawa, K., and Ohkubo, A. (1987) The nature of the mutagenicity and carcinogenicity of nitrated, aromatic compounds in the environment. Environ Health Perspect., 73, 191-199.
45. Boon, P.E., de Mul, A., van der Voet, H., van Donkersgoed, G., Brette, M., and van Klaveren, J.D. (2005) Calculations of dietary exposure to acrylamide. Mutat. Res., 580, 143-155.
46. Granvogl, M., Koehler, P., Latzer, L., and Schieberle, P. (2008) Development of a stable isotope dilution assay for the quantitation of glycidamide and its application to foods and model systems. J. Agric. Food Chem., 56, 6087-6092.
47. Williams, G.M., and Whysner, J. (1996) Epigenetic carcinogens: evaluation and risk assessment. Exp. Toxicol. Pathol., 48, 189-195.
48. Ellwein, L.B., and Cohen, S.M. (1990) The health risks of saccharin revisited. Crit. Rev. Toxicol., 20, 311-326.
49. Capen, C., Dybing, E., Rice, J., and Wilbourn, J. (1999) Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis, IARC, Lyon.
50. National Toxicology Program (1999) NTP Report on Carcinogens Background Document for Saccharin NTP.
51. National Toxicology Program (2005) Report on Carcinogens, 11th edn, U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. Appendix B.
52. International Agency for Research on Cancer (1999) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 73, IARC, Lyon, France, pp. 307-327.
53. Crowell, P.L. (1999) Prevention and therapy of cancer by dietary monoterpenes. J. Nutr., 129, 775S-778S.
54. Tsuda, H., Ohshima, Y., Nomoto, H., Fujita, K., Matsuda, E., Iigo, M. et al. (2004) Cancer prevention by natural compounds. Drug Metab. Pharmacokinet., 19, 245-263.
55. Goldin, B.R. (1990) Intestinal microflora: metabolism of drugs and carcinogens. Ann. Med., 22, 43-48.
56. Ehrlich, V.A., Nersesyan, A., H ölzl, C., Ferk, F., Bichler, J., and Knasmüller, S. (2006) Kanzerogene und genotoxische Pflanzeninhaltsstoffe, in Handbuch der Lebensmitteltoxikologie-Belastungen, Wirkungen, Lebensmittelsicherheit, Hygiene (eds D. Dunkelberg, T. Gebel and A. Hartwig), Wiley-VCH Verlag GmbH, Weinheim, Germany, pp. 1915-1963.
57. Poschl, G., and Seitz, H.K. (2004) Alcohol and cancer. Alcohol, 39, 155-165.
58. Bagnardi, V., Blangiardo, M., La Vecchia, C., and Corrao, G. (2001) Alcohol consumption and the risk of cancer: a meta-analysis. Alcohol Res. Health, 25, 263-270.
59. Thomas, D.B. (1995) Alcohol as a cause of cancer. Environ Health Perspect., 103 (Suppl. 8), 153-160.
60. Lutz, W.K., and Schlatter, J. (1992) Chemical carcinogens and overnutrition in diet-related cancer. Carcinogenesis, 13, 2211-2216.
61. Renehan, A.G., Tyson, M., Egger, M., Heller, R.F., and Zwahlen, M. (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 371, 569-578.
62. Lane, G. (2008) Obesity and gynaecological cancer. Menopause Int., 14, 33-37.
63. Chesson, A., and Collins, A. (1997) Assessment of the role of diet in cancer prevention. Cancer Lett., 114, 237-245.
64. Kada, T., Inoue, T., Morita, K., and Namiki, M. (1986) Dietary desmutagens. Prog. Clin. Biol. Res., 20, 6245-6253.
65. Kada, T., Inoue, T., and Namiki, M. (1982) Environmental desmutagens and antimutagens, in Environmental Mutagenesis and Plant Biology (ed. E.J. Klekowski), Praeger Scientific, New York, pp. 133-152.
66. Wattenberg, L.W. (1977) Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds. J. Natl. Cancer Inst., 58, 395-398.
67. Wattenberg, L.W. (1983) Inhibition of neoplasia by minor dietary constituents. Cancer Res., 43, 2448s-2453s.
68. Ribeiro, L.R., and Salvadori, D.M. (2003) Dietary components may prevent mutation-related diseases in humans. Mutat. Res., 544, 195-201.
69. El-Nezami, H.S., Polychronaki, N.N., Ma, J., Zhu, H.L., Ling, W.H., Salminen, E.K. et al. (2006) Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Am. J. Clin. Nutr., 83, 1199-1203.
70. Simonich, M.T., Egner, P.A., Roebuck, B.D., Orner, G.A., Jubert, C., Pereira, C. et al. (2007) Natural chlorophyll inhibits aflatoxin B1-induced multi-organ carcinogenesis in the rat. Carcinogenesis, 28, 1294-1302.
71. Cavin, C., Bezencon, C., Guignard, G., and Schilter, B. (2003) Coffee diterpenes prevent benzo[a]pyrene genotoxicity in rat and human culture systems. Biochem. Biophys. Res. Commun., 306, 488-495.
72. Wattenberg, L.W. (1990) Inhibition of carcinogenesis by naturally-occurring and synthetic compounds. Basic Life Sci., 52, 155-166.
73. Wood, A.W., Huang, M.T., Chang, R.L., Newmark, H.L., Lehr, R.E., Yagi, H. et al. (1982) Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid. Proc. Natl. Acad. Sci. U. S. A., 79, 5513-5517.
74. Huetz, P., Mavaddat, N., and Mavri, J. (2005) Reaction between ellagic acid and an ultimate carcinogen. J. Chem. Inf. Model, 45, 1564-1570.
75. Fuchs, S., Sontag, G., Stidl, R., Ehrlich, V., Kundi, M., and Knasmuller, S. (2008) Detoxification of patulin and ochratoxin A, two abundant mycotoxins, by lactic acid bacteria. Food Chem. Toxicol., 46, 1398-1407.
76. Schwab, C.E., Huber, W.W., Parzefall, W., Hietsch, G., Kassie, F., Schulte-Hermann, R. et al. (2000) Search for compounds that inhibit the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Crit. Rev. Toxicol., 30, 1-69.
77. Kassie, F., Rabot, S., Uhl, M., Huber, W., Qin, H.M., Helma, C. et al. (2002) Chemoprotective effects of garden cress (Lepidium sativum) and its constituents towards 2-amino-3-methyl-imidazo[4,5-f] quinoline (IQ)-induced genotoxic effects and colonic preneoplastic lesions. Carcinogenesis, 23, 1155-1161.
78. Huber, W.W., Rossmanith, W., Grusch, M., Haslinger, E., Prustomersky, S., Peter-Vorosmarty, B. et al. (2008) Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver. Food Chem. Toxicol., 46, 1230-1238.
79. Bartsch, H., Ohshima, H., and Pignatelli, B. (1988) inhibitors of endogenous nitrosation-mechanisms and implications in human cancer prevention. Mutat. Res., 202, 307-324.
80. Bartsch, H., Nair, J., and Owen, R.W. (1999) Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis, 20, 2209-2218.
81. Hecht, S.S. (2000) Inhibition of carcinogenesis by isothiocyanates. Drug Metab. Rev., 32, 395-411.
82. Knasmuller, S., Nersesyan, A., Misik, M., Gerner, C., Mikulits, W., Ehrlich, V. et al. (2008) Use of conventional and-omics based methods for health claims of dietary antioxidants: a critical overview. Br. J. Nutr., 99E (Suppl. 1), ES3-ES52.
83. Thimmulappa, R.K., Mai, K.H., Srisuma, S., Kensler, T.W., Yamamoto, M., and Biswal, S. (2002) Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res., 62, 5196-5203.
84. Yu, X., and Kensler, T. (2005) Nrf2 as a target for cancer chemoprevention. Mutat. Res., 591, 93-102.
85. Ohta, T. (1993) Modification of genotoxicity by naturally occurring flavorings and their derivatives. Crit. Rev. Toxicol., 23, 127-146.
86. Hoelzl, C., Lorenz, O., Haudek, V., Gundacker, N., Knasmüller, S., and Gerner, C. (2008) Proteome alterations induced in human white blood cells by consumption of Brussels sprouts: results of a pilot intervention study. Proteomics Clin. Appl., 2, 108-117.
87. Vineis, P., Veglia, F., Benhamou, S., Butkiewicz, D., Cascorbi, I., Clapper, M.L. et al. (2003) CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int. J. Cancer, 104, 650-657.
88. Taioli, E., Gaspari, L., Benhamou, S., Boffetta, P., Brockmoller, J., Butkiewicz, D. et al. (2003) Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years. Int. J. Epidemiol., 32, 60-63.
89. Agundez, J.A. (2004) Cytochrome P450 gene polymorphism and cancer. Curr. Drug Metab., 5, 211-224.
90. Aklillu, E., Carrillo, J.A., Makonnen, E., Hellman, K., Pitarque, M., Bertilsson, L. et al. (2003) Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1. Mol. Pharmacol., 64, 659-669.
91. Sweeney, C., Coles, B.F., Nowell, S., Lang, N.P., and Kadlubar, F.F. (2002) Novel markers of susceptibility to carcinogens in diet: associations with colorectal cancer. Toxicology, 181-182, 83-87.
92. Le Marchand, L., Donlon, T., Seifried, A., and Wilkens, L.R. (2002) Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev., 11, 1019-1024.
93. Terry, M.B., Gammon, M.D., Zhang, F.F., Knight, J.A., Wang, Q., Britton, J.A. et al. (2006) ADH3 genotype, alcohol intake and breast cancer risk. Carcinogenesis, 27, 840-847.
94. Yokoyama, A., and Omori, T. (2003) Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. Jpn. J. Clin. Oncol., 33, 111-121.
95. Gsur, A., Zidek, T., Schnattinger, K., Feik, E., Haidinger, G., Hollaus, P. et al. (2003) Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. Br. J. Cancer, 89, 702-706.
96. Kiyohara, C., Yoshimasu, K., Takayama, K., and Nakanishi, Y. (2006) EPHX1 polymorphisms and the risk of lung cancer-a HuGE review. Epidemiology, 17, 89-99.
97. Chen, Y., Bai, Y., Yuan, J., Chen, W., Sun, J., Wang, H. et al. (2006) Association of polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 genes with levels of DNA damage in peripheral blood lymphocytes among coke-oven workers. Cancer Epidemiol. Biomarkers Prev., 15, 1703-1707.
98. Pavanello, S., Pulliero, A., Siwinska, E., Mielzynska, D., and Clonfero, E. (2005) Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers. Carcinogenesis, 26, 169-175.
99. Palli, D., Masala, G., Peluso, M., Gaspari, L., Krogh, V., Munnia, A. et al. (2004) The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: a study on 634 subjects. Carcinogenesis, 25, 577-584.
100. Zheng, W., Deitz, A.C., Campbell, D.R., Wen, W.Q., Cerhan, J.R., Sellers, T.A. et al. (1999) N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 8, 233-239.
101. Deitz, A.C., Zheng, W., Leff, M.A., Gross, M., Wen, W.Q., Doll, M.A. et al. (2000) N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol. Biomarkers Prev., 9, 905-910.
102. Hou, S.M., Falt, S., Angelini, S., Yang, K., Nyberg, F., Lambert, B. et al. (2002) The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis, 23, 599-603.
103. Matullo, G., Peluso, M., Polidoro, S., Guarrera, S., Munnia, A., Krogh, V. et al. (2003) Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol. Biomarkers Prev., 12, 674-677.
104. Kinzler, K.W., and Vogelstein, B. (1997) Cancer-susceptibility genes. Gatekeepers and caretakers. Nature, 386, 761-763.
105. Margolin, S., and Lindblom, A. (2006) Familial breast cancer, underlying genes, and clinical implications: a review. Crit. Rev. Oncog., 12, 75-113.
106. Peltomaki, P. (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum. Mol. Genet, 10, 735-740.
107. Hung, R.J., Boffetta, P., Brockmoller, J., Butkiewicz, D., Cascorbi, I., Clapper, M.L. et al. (2003) CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis, 24, 875-882.
108. Pavanello, S., Simioli, P., Mastrangelo, G., Lupi, S., Gabbani, G., Gregorio, P. et al. (2002) Role of metabolic polymorphisms NAT2 and CYP1A2 on urinary mutagenicity after a pan-fried hamburger meal. Food Chem. Toxicol., 40, 1139-1144.
109. Le Marchand, L., Hankin, J.H., Wilkens, L.R., Pierce, L.M., Franke, A., Kolonel, L.N. et al. (2001) Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev., 10, 1259-1266.
110. McGlynn, K.A., Rosvold, E.A., Lustbader, E.D., Hu, Y., Clapper, M.L., Zhou, T.L. et al. (1995) Susceptibility to hepatocellular-carcinoma is associated with genetic-variation in the enzymatic detoxification of aflatoxin B-1. Proc. Natl. Acad. Sci. U. S. A., 92, 2384-2387.
111. Reszka, E., Wasowicz, W., and Gromadzinska, J. (2006) Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility. Br. J. Nutr., 96, 609-619.
112. Hoeijmakers, J.H.J. (2001) Genome maintenance mechanisms for preventing cancer. Nature, 411, 366-374.
113. Zienolddiny, S., Campa, D., Lind, H., Ryberg, D., Skaug, V., Stangeland, L. et al. (2006) Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis, 27, 560-567.
114. Bjelakovic, G., Nikolova, D., Simonetti, R.G., and Gluud, C. (2004) Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet, 364, 1219-1228.
115. Kassie, F., and Knasmüller, S. (2004) Glucosinolates and the prevention of cancer, in Functional Foods, Ageing and Degenerative Disease (eds C. Remacle and B. Reusens), CRC Press, Woodhead Publishing Limited, Cambridge England, Boca Raton, Boston, New York, Washington, DC, pp. 615-623.
116. Tempfer, C.B., Hefler, L.A., Schneeberger, C., and Huber, J.C. (2006) How valid is single nucleotide polymorphism (SNP) diagnosis for the individual risk assessment of breast cancer? Gynecol. Endocrinol., 22, 155-159.
117. AICR (2007) Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspectiv, World Cancer Research Fund/American Institute for Cancer Research, Washington, DC, p. 517.
118. Belpomme, D., Irigaray, P., Sasco, A.J., Newby, J.A., Howard, V., Clapp, R. et al. (2007) The growing incidence of cancer: role of lifestyle and screening detection (Review). Int. J. Oncol., 30, 1037-1049.
119. Pembrey, M.E., Bygren, L.O., Kaati, G., Edvinsson, S., Northstone, K., Sjöström, M., Golding, J., and The ALSPAC Study Team (2006) Sex-specific, male-line transgenerational responses in humans. Eur. J. Hum. Genet., 14, 159-166.
120. Luebeck, E.G., Moolgavkar, S.H., Liu, A.Y., Boynton, A., and Ulrich, C.M. (2008) Does folic acid supplementation prevent or promote colorectal cancer? Results from model-based predictions. Cancer Epidemiol. Biomarkers Prev., 17, 1360-1367.
121. Fenech, M. (2005) The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis. Mutagenesis, 20, 255-269.